Search results
Results from the WOW.Com Content Network
The gene affected is the HPD gene encoding 4-hydroxyphenylpyruvic acid dioxygenase, on chromosome 12q24. [4] It is unusual in that most other inborn errors of metabolism are caused by loss-of-function mutations, and hence have recessive inheritance (condition occurs only if both copies are mutated).
Tyrosinemia type III is a rare disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27), encoded by the gene HPD. [2] This enzyme is abundant in the liver, and smaller amounts are found in the kidneys. It is one of a series of enzymes needed to break down tyrosine.
HPPD also catalyzes the conversion of phenylpyruvate to 2-hydroxyphenylacetate and the conversion of α-ketoisocaproate to β-hydroxy β-methylbutyrate. [2] [3] HPPD is an enzyme that is found in nearly all aerobic forms of life. [4] This reaction shows the conversion of 4-hydroxyphenylpyruvate into homogentisate by HPPD.
4-Hydroxyphenylpyruvic acid (4-HPPA) is an intermediate in the metabolism of the amino acid phenylalanine. The aromatic side chain of phenylalanine is hydroxylated by the enzyme phenylalanine hydroxylase to form tyrosine. The conversion from tyrosine to 4-HPPA is in turn catalyzed by tyrosine aminotransferase. [2]
4-Hydroxyphenylpyruvate dioxygenase (HPPD) is an enzyme found in both plants and animals, which catalyzes the catabolism of the amino acid tyrosine. [4] Preventing the breakdown of tyrosine has three negative consequences: the excess of tyrosine stunts growth; the plant suffers oxidative damage due to lack of tocopherols (vitamin E); and ...
Israel's campaign has killed more than 45,000 Palestinians, displaced most of the 2.3 million population and reduced much of the coastal enclave to ruins. On Thursday, Human Rights Watch said ...
Campbell makes about $67,000 in base salary each week under the one-year $5 million contract he signed in March. Campbell also will miss the chance to earn $60,000 in weekly roster bonuses and the ...
Specific targets include 4-hydroxyphenylpyruvic acid dioxygenase (hppD) and indolepyruvate ferredoxin oxidoreductase (ior). These enzymes are involved in phenylalanine and tyrosine catabolism. Other possible targets include glycerol kinase and substrate binding proteins in ATP-binding cassette transporters (ABC transporters). [ 5 ]